Zomedica Corp. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Q4 2024 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q1 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q2 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q3 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q4 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Zomedica Corp. Earnings Date And Information
Zomedica Corp. last posted its earnings results on Wednesday, March 15th, 2023. The company reported $-0.01 earnings per share for the quarter, missing analysts' consensus estimates of $-0.00714 by $0.00286. The company had revenue of 7.00 M for the quarter and had revenue of 25.19 M for the year. Zomedica Corp. has generated $0 earnings per share over the last year ($-0.0352 diluted earnings per share) and currently has a price-to-earnings ratio of -2.04. Zomedica Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Zomedica Corp. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/07/2024 | Q3 2025 | -$0.01 | $8.70 M | $7.00 M | ||
08/14/2024 | Q2 2025 | -$0.02 | $8.36 M | $6.13 M | ||
05/09/2024 | Q1 2025 | -$0.01 | $6.26 M | |||
04/01/2024 | Q4 2024 | -$0.02 | $7.34 M | |||
11/13/2023 | Q3 2024 | -$0.00 | $8.29 M | $6.35 M | ||
08/10/2023 | Q2 2024 | -$0.01 | $7.34 M | $6.02 M | ||
05/11/2023 | Q1 2024 | -$0.01 | $5.48 M | |||
03/15/2023 | Q4 2023 | -$0.01 | -$0.00 | 0 | $6.16 M | |
11/14/2022 | Q3 2023 | -$0.01 | $4.78 M | |||
08/15/2022 | Q2 2023 | -$0.01 | $4.25 M | |||
05/10/2022 | Q1 2023 | -$0.00 | $3.75 M | |||
03/01/2022 | Q4 2022 | -$0.00 | $4.08 M | |||
11/12/2021 | Q3 2022 | -$0.01 | $1.50 M | $22,514 | ||
08/11/2021 | Q2 2022 | -$0.01 | $1.10 M | $15,693 | ||
05/12/2021 | Q1 2022 | -$0.00 | $14,124 | |||
02/26/2021 | Q4 2021 | -$0.00 | $0 | |||
11/12/2020 | Q3 2021 | -$0.01 | $0 | |||
08/10/2020 | Q2 2021 | -$0.01 | -$0.02 | -0.01 | $0 | |
05/11/2020 | Q1 2021 | -$0.02 | -$0.02 | -0 | $0 | |
02/26/2020 | Q4 2020 | -$0.02 | -$0.02 | -0 | $0 |
Zomedica Corp. Earnings: Frequently Asked Questions
-
When is Zomedica Corp.'s earnings date?
Zomedica Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
-
How can I listen to Zomedica Corp.'s earnings conference call?
The conference call for Zomedica Corp.'s latest earnings report can be listened to online.
-
How can I read Zomedica Corp.'s conference call transcript?
The conference call transcript for Zomedica Corp.'s latest earnings report can be read online.
-
How much revenue does Zomedica Corp. generate each year?
Zomedica Corp. (:ZOM) has a recorded annual revenue of $25.19 M.
-
How much profit does Zomedica Corp. generate each year?
Zomedica Corp. (:ZOM) has a recorded net income of $25.19 M. Zomedica Corp. has generated $-0.0352 earnings per share over the last four quarters.
-
What is Zomedica Corp.'s price-to-earnings ratio?
Zomedica Corp. (:ZOM) has a price-to-earnings ratio of -2.04 and price/earnings-to-growth ratio is 0.18.